Vasily V. Sinyov

Vasily V. Sinyov

Auto-generated profile, based on publicly available information

Vasily V. Sinyov

Department of Cardiovascular Pathology, Chazov National Medical Research Center of Cardiology, 121552 Moscow, Russia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
ARAnastasiya Ryzhkova
Anastasiya Ryzhkova
Margarita A. SazonovaMargarita A. Sazonova
Margarita A. Sazonova
VSVasily V Sinyov
Vasily V Sinyov
EGElena V Galitsyna
Elena V Galitsyna
MCMariуa Chicheva
Mariуa Chicheva
TSTatiana P Shkurat
Tatiana P Shkurat
Mitochondrial diseases caused by mtDNA mutations: a mini-review Anastasia I Ryzhkova,1,2 Margarita A Sazonova,1,3 Vasily V Sinyov,1 Elena V Galitsyna,4 Mariya M Chicheva,4 Alexandra A Melnichenko,4 Andrey V Grechko,5 Anton Yu Postnov,1 Alexander N Orekhov,3,6 Tatiana P Shkurat4 1Laboratory of Medical Genetics, National Medical Research Center of Cardiology, Moscow, Russian Federation; 2Department of Virology, K.I. Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology-MVA, Moscow, Russian Federation; 3Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Moscow, Russian Federation; 4Department of Genetics, Southern Federal University, Rostov-on-Don, Russian Federation; 5Federal Research and Clinical Center of Reanimatology and Rehabilitology, Moscow, Russian Federation; 6Institute for Atherosclerosis Research, Skolkovo Innovative Centre, Moscow Region, Russian Federation There are several types of mitochondrial cytopathies, which cause a set of disorders, arise as a result of mitochondria’s failure. Mitochondria’s functional disruption leads to development of physical, growing and cognitive disabilities and includes multiple organ pathologies, essentially disturbing the nervous and muscular systems. The origins of mitochondrial cytopathies are mutations in genes of nuclear DNA encoding mitochondrial proteins or in mitochondrial DNA. Nowadays, numerous mtDNA mutations significant to the appearance and progress of pathologies in humans are detected. In this mini-review, we accent on the mitochondrial cytopathies related to mutations of mtDNA. As well known, there are definite set of symptoms of mitochondrial cytopathies distinguishing or similar for different syndromes. The present article contains data about mutations linked with cytopathies that facilitate diagnosis of different syndromes by using genetic analysis methods. In addition, for every individual, more effective therapeutic approach could be developed after wide-range mutant background analysis of mitochondrial genome. Keywords: mitochondrial cytopathy, mitochondrial dysfunction, mtDNA mutation, mitochondrial gene mutation

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Margarita A. SazonovaMargarita A. Sazonova
Margarita A. Sazonova
VSVasily V Sinyov
Vasily V Sinyov
ARAnastasiya Ryzhkova
Anastasiya Ryzhkova
EGElena V Galitsyna
Elena V Galitsyna
ZKZukhra B Khasanova
Zukhra B Khasanova
ISIgor Sobenin
Igor Sobenin
Mutations of mtDNA, due to their higher frequency of occurrence compared to nuclear DNA mutations, are the most promising biomarkers for assessing predisposition of the occurrence and development of atherogenesis. The aim of the present article was an analysis of correlation of several mitochondrial genome mutations with carotid atherosclerosis. Leukocytes from blood of study participants from Moscow polyclinics were used as research material. The sample size was 700 people. The sample members were diagnosed with “atherosclerosis” on the basis of ultrasonographic examination and biochemical and molecular cell tests. DNA was isolated from blood leukocyte samples of the study participants. PCR fragments of DNA, containing the region of 11 investigated mutations, were pyrosequenced. The heteroplasmy level of these mutations was detected. Statistical analysis of the obtained results was performed using the software package SPSS 22.0. According to the obtained results, an association of mutations m.652delG, m.3336C>T, m.12315G>A, m.14459G>A m.15059G>A with carotid atherosclerosis was found. These mutations can be biomarkers for assessing predisposition to this disease. Additionally, two single nucleotide substitutions (m.13513G>A and m.14846G>A), negatively correlating with atherosclerotic lesions, were detected. These mutations may be potential candidates for gene therapy of atherosclerosis and its risk factors.

20 December 2014 in Gerontology
Verified
Journal Article
Closed access
PDF file
ISIgor Sobenin
Igor Sobenin
AZAndrey Zhelankin
Andrey Zhelankin
VSVasily V. Sinyov
Vasily V. Sinyov
YBYuri Bobryshev
Yuri Bobryshev
AOAlexander N. Orekhov
Alexander N. Orekhov
Atherosclerosis is a complex disease which can be described as an excessive fibrofatty, proliferative, inflammatory response to damage to the artery wall involving several cell types such as smooth muscle cells, monocyte-derived macrophages, lymphocytes, dendritic cells and platelets. On the other hand, atherosclerosis is a typical age-related degenerative pathology, which is characterized by signs of cell senescence in the arterial wall including reduced cell proliferation, irreversible growth arrest and apoptosis, increased DNA damage, the presence of epigenetic modifications, shortening of telomere length and mitochondrial dysfunction. The most prominent characteristics of mitochondrial aging are their structural alterations and mitochondrial DNA damage. The mechanisms of mitochondrial genome damage in the development of chronic age-related diseases such as atherosclerosis are not yet well understood. This review focuses on the latest findings from studies of those mutations of the mitochondrial genome which may play an important role in the development of atherosclerosis and which are, at the same time, also markers of mitochondrial aging and cell senescence.

3 January 2015 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
ISIgor Sobenin
Igor Sobenin
AZAndrey Zhelankin
Andrey Zhelankin
KMKonstantin Y. Mitrofanov
Konstantin Y. Mitrofanov
VSVasily V. Sinyov
Vasily V. Sinyov
Margarita A. SazonovaMargarita A. Sazonova
Margarita A. Sazonova
AOAlexander N. Orekhov
Alexander N. Orekhov
Atherosclerosis, the primary cause of cardiovascular disease, is a complex and multifactorial pathology resulted from the harmful interactions between genetic and environmental factors. There is a growing body of evidence in support of the role of mitochondrial factors in the pathogenesis of atherosclerosis. Impaired mitochondrial function and structural and qualitative changes in mitochondrial components such as mitochondrial DNA (mtDNA) damage may be directly involved in the development of multiple mechanisms of atherogenesis. Recent findings show that several heteroplasmic mutations of mtDNA are related to atherosclerosis, coronary heart disease and several atherosclerosis-related diseases such as arterial hypertension and diabetes mellitus. Therefore, heteroplasmic mtDNA mutations could represent a promising molecular biomarker of genetic susceptibility to atherosclerosis and related pathologies. This review is focused on the latest findings in the studies of mutations of mitochondrial genome, which are associated with atherosclerosis and atherosclerosis- related diseases.

6 September 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
ISIgor Sobenin
Igor Sobenin
AZAndrey Zhelankin
Andrey Zhelankin
ZKZukhra Khasanova
Zukhra Khasanova
VSVasily V. Sinyov
Vasily V. Sinyov
LMLyudmila V. Medvedeva
Lyudmila V. Medvedeva
Alexander N. OrekhovAlexander N. Orekhov
Alexander N. Orekhov
Mitochondrial dysfunction and oxidative stress are likely involved in atherogenesis. Since the mitochondrial genome variation can alter functional activity of cells, it is necessary to assess the presence in atherosclerotic lesions of mitochondrial DNA (mtDNA) heteroplasmic mutations known to be associated with different pathological processes and ageing. In this study, mtDNA heteroplasmy and copy number (mtCN) were evaluated in the autopsy-derived samples of aortic intima differing by the type of atherosclerotic lesions. To detect mtDNA heteroplasmic variants, next generation sequencing was used, and mtCN measurement was performed by qPCR. It was shown that mtDNA heteroplasmic mutations are characteristic for particular areas of intimal tissue; in 83 intimal samples 55 heteroplasmic variants were found; mean minor allele frequencies level accounted for 0.09, with 12% mean heteroplasmy level. The mtCN variance measured in adjacent areas of intima was high, but atherosclerotic lesions and unaffected intima did not differ significantly in mtCN values. Basing on the ratio of minor and major nucleotide mtDNA variants, we can conclude that there exists the increase in the number of heteroplasmic mtDNA variants, which corresponds to the extent of atherosclerotic morphologic phenotype.

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Margarita A. SazonovaMargarita A. Sazonova
Margarita A. Sazonova
VSVasily V Sinyov
Vasily V Sinyov
ARAnastasiya Ryzhkova
Anastasiya Ryzhkova
EGElena V Galitsyna
Elena V Galitsyna
AMAlexandra A Melnichenko
Alexandra A Melnichenko
ISIgor Sobenin
Igor Sobenin
Modelling of pathological processes in cells is one of the most sought‐after technologies of the 21st century. Using models of such processes may help to study the pathogenetic mechanisms of various diseases. The aim of the present study was to analyse the literature, dedicated to obtaining and investigating cybrid models. Besides, the possibility of modeling pathological processes in cells and treatment of different diseases using the models was evaluated. Methods of obtaining Rho0 cell cultures showed that, during their creation, mainly a standard technique, based on the use of mtDNA replication inhibitors (ethidium bromide), was applied. Cybrid lines were usually obtained by PEG fusion. Most frequently, platelets acted as donors of mitochondria. According to the analysis of the literature data, cybrid cell cultures can be modeled to study the dysfunction of the mitochondrial genome and molecular cellular pathological processes. Such models can be very promising for the development of therapeutic approaches to the treatment of various human diseases.